Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. - Wikidata - wikimedia - TriplyDB

Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.

Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.

http://www.wikidata.org/entity/Q45086778

about

Devices in the management of advanced, chronic heart failure Mechanical circulatory assist devices: a primer for critical care and emergency physicians Remote hemodynamic monitoring for ambulatory left ventricular assist device patients New Insights in the Diagnosis and Treatment of Heart Failure Preload sensitivity in cardiac assist devices Why pulsatility still matters: a review of current knowledge Functional status in left ventricular assist device-supported patients: a literature review Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment Current state-of-the-art of device therapy for advanced heart failure A randomized controlled pilot trial to improve advance care planning for LVAD patients and their surrogates.The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results Complications of Continuous-Flow Mechanical Circulatory Support Devices.Clinical outcomes after continuous-flow left ventricular assist device: a systematic review Effect of left ventricular assist device implantation and heart transplantation on habitual physical activity and quality of life.Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence.Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation.The impact of insurance and socioeconomic status on outcomes for patients with left ventricular assist devices Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011.Ventricular assist device use in congenital heart disease with a comparison to heart transplant Predictors of right ventricular failure after left ventricular assist device implantation.Change in health-related quality of life from before to after destination therapy mechanical circulatory support is similar for older and younger patients: analyses from INTERMACS.Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life.Long-term continuous-flow left ventricular assist devices (LVAD) as bridge to heart transplantation Incidence and predictors of cognitive decline in patients with left ventricular assist devices.A single strain-based growth law predicts concentric and eccentric cardiac growth during pressure and volume overload Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.Initial In Vivo Evaluation of a Novel Left Ventricular Assist Device Current status of mechanical circulatory support: a systematic review.Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation?Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.Comparison of effects of extra-thoracic paraaortic counterpulsation to intraaortic balloon pump on circulatory support in acute heart failure.Mechanical discoordination increases continuously after the onset of left bundle branch block despite constant electrical dyssynchrony in a computational model of cardiac electromechanics and growth.Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?Patients' decision making process and expectations of a left ventricular assist device pre and post implantation.Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.A review of ethical considerations for ventricular assist device placement in older adults Development of a Double-Lumen Cannula for a Percutaneous RVAD.

P2860

Q24630052-947BFA67-B647-46AF-8F5A-799244BBDB8B Q26747170-95D8532E-5931-4C25-8873-F616A0C6C518 Q26770287-4E0990AB-F755-43A2-947F-A4FDDA93924C Q26774884-7C5DD2DA-EBE4-416B-9D19-FB2182101607 Q26853212-F601462C-4F96-43BC-85C9-19C705ED43E0 Q26864718-4D463E72-D21C-4828-8039-5D719FF69976 Q26995718-5E4431D7-B37A-4D33-8B15-9E28C8C24FA4 Q28075310-800EEC86-C01D-43DB-8A65-90228CC80BC0 Q28081412-3EB4F87F-CA9B-4D18-9C2B-F3505E4AE4D3 Q30277199-FEBA4FD3-F8D1-45BE-B204-222E95590BA6 Q30359726-24E5216F-B3C5-4430-A09F-9BAB1D14B64E Q30409848-986C4C75-EC3D-43E5-A68B-37B55F4B8CBA Q30601099-C15843B3-1118-4F37-B4C1-8F2C3D8A9D73 Q33770709-0CC06F48-1256-45AE-B1E6-34BE8E2624DF Q33951341-645D4E15-54B2-4887-BEA7-5925DC5E793B Q33951353-7181CF51-80BD-40DE-821B-E43F0C6502A1 Q34006019-1F835A5E-24C0-4FC4-9DA1-A831D0D81B72 Q34160865-9C16408E-CFA7-4F27-A26D-30B4A0380B71 Q34304763-D7507FE0-C842-48F5-B8AC-2B3F188FB741 Q34510391-00517807-497F-4B2F-AEA7-CAC030663BA8 Q34965572-6F27FFB7-7B21-46D4-8BD7-41FAC4C52150 Q35085888-1E63ECCE-8651-4820-B5B5-1B5C1E9B11A2 Q35137197-7AB9BB5D-848F-4D28-B381-86FF1E47F8DD Q35290569-F906F59B-97AE-497D-8E69-5364139F4112 Q35564908-E3511F3B-AA8C-475F-BCC5-CCCA00EC1EB1 Q35982552-B7F4B641-2FF3-4AA4-B613-4A0CCE74E63C Q36055153-5E168A5A-4546-4D62-A7B8-6C4F6D685560 Q36116040-B116B811-E557-418C-9CD2-C225E7B0821C Q36204026-3861C5A5-3293-4190-813C-41D50B36F3FF Q36206550-A01E64EF-3422-4C26-B164-AC085623DDEF Q36238406-0B8B0D5C-1A04-4243-8123-B4E9587FC447 Q36306558-8E436195-E052-4514-ADD8-AED3DE14AADA Q36318337-A924B0AB-C44A-454F-B56E-D316C951D09A Q36351820-25E48EB3-29A5-4DED-8FE9-CDC27C1E6667 Q36374838-9F60B5D7-2349-4EBF-B96D-40CC88CFEE45 Q36597965-A7F93D3F-416F-4965-BDDA-96586D80149D Q36654892-6037988A-B852-4AD1-A993-D9140F31F032 Q36707966-197B5EB3-7FBF-4F9E-AF89-F5CCFABAE3A7 Q36859904-46E0706C-E7B3-4D99-B1FC-6FB3B57F4124 Q36868932-7AC39795-A51E-4875-A59D-69AAF2A04220

P2860

Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.

http://www.wikidata.org/entity/Q45086778

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Continuous flow left ventricul ...... vanced heart failure patients.

@en

Continuous flow left ventricul ...... vanced heart failure patients.

@nl

type

label

Continuous flow left ventricul ...... vanced heart failure patients.

@en

Continuous flow left ventricul ...... vanced heart failure patients.

@nl

prefLabel

Continuous flow left ventricul ...... vanced heart failure patients.

@en

Continuous flow left ventricul ...... vanced heart failure patients.

@nl

P1433

Q45086778-AAC056BD-90F8-415F-8BD4-0E46F2FCB7BB

P1476

Q45086778-17344D41-11E1-4374-BC0D-7E2361075A7E

P2093

Q45086778-184E4267-3155-4F06-A2DE-F4608E40D6A5

Q45086778-1CF5B58B-CF8B-4F51-9DA9-BA2D3A0EAF72

Q45086778-2EBF9C4C-1A6A-4C7C-84E5-4A833AC58FB9

Q45086778-3F781233-9EB7-4F8D-9774-16121EA9F7A8

Q45086778-43B7F2C3-8FF8-4556-AF22-C90129A237E4

Q45086778-4714B490-77A9-486C-8F78-D1207B0E63C3

Q45086778-56DE2A2D-C168-4CB6-8B2E-21C15804F0B1

Q45086778-7C4D72B3-97A8-4679-B77D-3E557571FF53

Q45086778-9D2CB490-0E59-4F08-AEB7-330F9C18D721

Q45086778-B67D0741-62F6-4127-87CC-0B87874F4BB3

P304

Q45086778-E7E70654-995B-456C-AC07-47E4CB97ADAD

P31

Q45086778-CD6E119A-4881-4160-98FD-2A79E19DBD0B

P356

Q45086778-AE998D5B-C690-4CD1-AFD0-622A7718318C

P407

Q45086778-9A936ADF-7D89-476C-A727-33FF7C0ACFA5

P433

Q45086778-B3E45992-EBFF-4F2C-978C-5F29444B71CE

P478

Q45086778-D0893C74-9F54-41F3-9C94-D2B397681712

P50

Q45086778-2ECFEA28-070D-454E-B1F1-6FE28AD074AD

P577

Q45086778-7A07ABE3-C00A-449A-B32E-75BC3D0D655B

P5875

Q45086778-6B4093D1-4883-472A-A2C4-1057A967BACF

P698

Q45086778-340A457C-BB13-4AA6-A0D2-14D7185972E1

P921

Q45086778-C2235C5E-BF27-4868-80B3-98080D5541EB

Q45086778-D93B1259-61AB-4380-A97D-F640458308AA

P356

J.JACC.2009.12.052

P1433

Journal of the American College of Cardiology

P1476

Continuous flow left ventricul ...... vanced heart failure patients.

@en

P2093

Andrew J Boyle

http://www.w3.org/2001/XMLSchema#string

Brooks S Edwards

http://www.w3.org/2001/XMLSchema#string

Carmelo A Milano

http://www.w3.org/2001/XMLSchema#string

David J Farrar

http://www.w3.org/2001/XMLSchema#string

HeartMate II Investigators

http://www.w3.org/2001/XMLSchema#string

John V Conte

http://www.w3.org/2001/XMLSchema#string

Joseph G Rogers

http://www.w3.org/2001/XMLSchema#string

Keith D Aaronson

http://www.w3.org/2001/XMLSchema#string

Mark S Slaughter

http://www.w3.org/2001/XMLSchema#string

Ranjit John

http://www.w3.org/2001/XMLSchema#string

P304

1826-1834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2009.12.052

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Francis D. Pagani

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43298649

http://www.w3.org/2001/XMLSchema#string

P698

20413033

http://www.w3.org/2001/XMLSchema#string

P921

quality of life